机构:[1]Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Key Laboratory of Neurodegenerative Diseases (Capital Medical University), Ministry of Education, Beijing, China神经变性病教育部重点实验室首都医科大学宣武医院首都医科大学•脑血管病研究所[2]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China[3]Department of Neurosurgery, Beijing Tongren Hospital,Capital Medical University, Beijing, China
Background and Purpose-p53-mediated neuronal death is a central pathway of stroke pathophysiology, but its mechanistic details remain unclear. Here, we identified a novel microRNA mechanism that downregulation of inhibitory member of the apoptosis-stimulating proteins of p53 family (iASPP) by the brain-specific microRNA-124 (miR-124) promotes neuronal death after cerebral ischemia. Methods-In a mouse model of focal permanent cerebral ischemia, the expression of iASPP and miR-124 was quantified by reverse transcription quantitative real-time polymerase chain reaction, immunofluorescence staining, and Western blot. Luciferase reporter assay was used to validate whether miR-124 can directly bind to the 3'-untranslated region of iASPP mRNA. To evaluate the role of miR-124, miR-124 mimic and its inhibitor were transfected into Neuro-2a cells and C57 mice. Results-There was no change in the iASPP mRNA level in cerebral ischemia. However, iASPP protein was remarkably decreased, with a concurrent elevation in miR-124 level. Furthermore, miR-124 can bind to the 3'-untranslated region of iASPP in 293T cells and downregulate its protein levels in Neuro-2a cells. In vivo, infusion of miR-124 decreased brain levels of iASPP, whereas inhibition of miR-124 enhanced iASPP levels and significantly reduced infarction in mouse focal cerebral ischemia. Conclusions-These data demonstrate that p53-mediated neuronal cell death after stroke can be nontranscriptionally regulated by a novel mechanism involving suppression of endogenous cell death inhibitors by miR-124. Further dissection of microRNA regulatory mechanisms may lead to new therapeutic opportunities for preventing neuronal death after stroke.
基金:
the Natural Science Foundation of China (grant no. 81000504, 81171241)
Beijing Natural Science Foundation (grant no. 7132112)
第一作者机构:[1]Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Key Laboratory of Neurodegenerative Diseases (Capital Medical University), Ministry of Education, Beijing, China[2]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China
通讯作者:
通讯机构:[*1]Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, 45 Changchun St, Beijing 100053, China.
推荐引用方式(GB/T 7714):
Xiangrong Liu,Fang Li,Shangfeng Zhaop,et al.MicroRNA-124-Mediated Regulation of Inhibitory Member of Apoptosis-Stimulating Protein of p53 Family in Experimental Stroke[J].STROKE.2013,44(7):1973-80.doi:10.1161/STROKEAHA.111.000613.
APA:
Xiangrong Liu,Fang Li,Shangfeng Zhaop,Yumin Luo,Jun Kang...&Xunming Ji.(2013).MicroRNA-124-Mediated Regulation of Inhibitory Member of Apoptosis-Stimulating Protein of p53 Family in Experimental Stroke.STROKE,44,(7)
MLA:
Xiangrong Liu,et al."MicroRNA-124-Mediated Regulation of Inhibitory Member of Apoptosis-Stimulating Protein of p53 Family in Experimental Stroke".STROKE 44..7(2013):1973-80